Latest Data & Signals Issued

Below are some of the latest signals issued for BioVie Inc

General

Signal Type Signal Value Data
Score 2.307 3 days ( -10.74 %
Last Price $1.65 -2.94 %
Performance History
7 Days
$1.48 $1.65
11.49%
30 Days
$1.72 $1.65
-4.07%
12 Mos
$1.11 $1.65
48.65%

8/18

Active Buy Signals

Specific Signals

Short Term
Net score: 54.49
Signal Type Signal Value Importance Data
High / Low Neutral Very Low $1.55 - $1.68
Position: 76.92% from low / 23.08% from high · Momentum: 10.70%
Trend - 3 mos 8.85 % High Width: 34.30 %
Pred. range - 3 mos $1.43 - $1.92 Low -13.16 % - 16.63 %
Volume Direction Sell High Volume: 158,585 · Direction: 0
Pivot Short Sell Very Low Jun 02, 2026 - 2 days
RSI Short Pivot Signal Sell Very Low Jun 02, 2026 - 2 days
Short MA 3 mos Sell Low May 28, 2026 - 5 days
Long MA 3 mos Buy Medium May 29, 2026 - 4 days
Short/Long MA 3 mos Buy Medium Jun 01, 2026 - 3 days

Unlock Short Term Signals

Get access to powerful short-term trading signals and real-time market insights

Subscribe Now
Long Term
Net score: 68.9
Signal Type Signal Value Importance Data
Trend - 12 mos -25.96 % Very High Width: 620.43 %
Pred. range - 12 mos N/A - $5.09 High -100.00 % - 208.49 %
Short MA 12 mos Buy Very High May 29, 2026 - 4 days
Long MA 12 mos Buy Very High May 13, 2026 - 15 days
Short/Long MA 12 mos Buy Very High Mar 24, 2026 - 50 days
Pivot Long Sell Low Jul 18, 2025 - 221 days
RSI Long Pivot Signal Sell Low Jun 02, 2026 - 2 days
Bollinger Buy Medium Apr 17, 2026 - 33 days
MACD Buy High No Dates Stored For This Signal

Signals Effectiveness

Backtesting is not only a way to check stock signal accuracy, but also a tool to continually improvement. Data can be used for self adjustment as each stock has an individual behavior.

Accuracy and return is not the same. A stock signal may provide low statistical accuracy, but the signals may prove high return in average.

Sharp market dips or fundamental changes (earning reports, news updates etc), may force a short term reaction and disturb the signals (Signals may jump quickly from buy to sell, just to return to buy).

Click to get the best stock tips daily for free!
ABOUT BIOVIE INC
BioVie
BioVie Inc., a clinical stage biotechnology company, engages in the discovery, development, and commercialization of drugs therapies in the United States. Its products in pipeline include BIV201, which completed Phase IIa clinical trial for the treatment of ascites due to chronic liver cirrhosis; and NE3107, which is in Phase III clinical trial for the treatment of patients with mild to moderate Alzheimer's disease and Phase I clinical trial for ...
GOLDEN STAR
Ticker Change Signal Date
LITE
$905.00
3.65% Jun 01
RUN
$12.83
15.74% May 06
GLBE
$31.61
0.569% May 05
SAP
$172.39
4.80% May 05
ADBE
$243.57
5.20% Apr 29

Top Fintech Company

StockInvest.us featured in The Global Fintech Index 2020 as the top Fintech company of the country.

Full report by FINDEXABLE